Cancerappy logo — Artificial intelligence to optimize cancer drug development

Cancerappy

Artificial intelligence to optimize cancer drug development

Founded 2019 Spain Spain 6 employees AI, Big Data +1

General Information

Company Name Cancerappy
Founded Year 2019
Location Spain Spain
Employees 6
Industries AI, Big Data, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Cancerappy. To contact Cancerappy, visit cancerappy.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cancerappy compare?

A PDF of Cancerappy and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cancerappy soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cancerappy

CancerAppy is a biotech startup based in Spain that is utilizing artificial intelligence to enhance the development of cancer drugs. The company's focus lies in the discovery and development of new therapeutic targets using its proprietary AI methodology. Established in 2019, CancerAppy operates within the Big Data and Health Care industries. CancerAppy's commitment to revolutionizing cancer drug development by harnessing the power of AI is a compelling proposition in the rapidly evolving healthcare landscape. With a strong base in a country that boasts a burgeoning tech ecosystem and significant research capabilities, the potential for the startup to make an impact is promising. As of now, there is no public record of investments or investors in the latest round. However, given the innovative nature of CancerAppy's work and the growth trajectory of AI in healthcare, the startup presents an intriguing opportunity for venture capital firms seeking to support groundbreaking advancements in cancer treatment.

Business keywords: biotech, cancer research, therapeutic targets, big data, drug discovery, oncology, insilico drug design, cancer therapies, new therapeutic targets, biomedical technology, startup, investigation

No funding data available for Cancerappy yet.

Cancerappy Alternatives & Competitors

View All Alternatives
Cancerappy vs
Bainom
Bainom United States

Unlocking clinical insights by decoding intricate multi-omic patterns.

Pre-Seed
2 employees
AI, Analytics
Cancerappy vs

Micar Innovation - Drug Discovery Factory for novel drug molecules (structure based in silico drug d...

3 employees
AI, Biotechnology
Cancerappy vs
iktos
iktos France

Artificial intelligence for new drug design

Series A
85 employees
AI, Biotechnology

FAQ About Cancerappy

Artificial intelligence to optimize cancer drug development
Cancerappy was founded in 2019.
Cancerappy is headquartered in Spain.
Cancerappy operates in AI, Big Data and Health Care. Its work centres on biotech, cancer research, therapeutic targets and big data.
Cancerappy has approximately 6 employees.
Top alternatives and competitors to Cancerappy include Bainom, Micar Innovation (Micar21), iktos, NetTargets, (주)넷타겟, Data4Cure, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cancerappy and Bainom are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cancerappy, https://bouncewatch.com/company/cancerappy, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes